The score for allergic rhinitis (SFAR): a simple and valid assessment method in population studies

Annesi‐Maesano, Isabella; Didier, A.; Klossek, M.; Chanal, I.; Moreau, David; Bousquet, Jean

doi:10.1034/j.1398-9995.2002.1o3170.x

Cited by 156 publications

(132 citation statements)

References 14 publications

Supporting

Mentioning

125

Contrasting

Unclassified

Order By: Relevance

“…17 The SFAR was shown to be highly correlated with objective markers of immediate hypersensitivity such as specific IgE and skin prick test positivity. 34 For the purpose of the present genetic study, familial resemblance of rhinitis was not introduced in the computation of the score.…”

Section: Phenotypes Analyzedmentioning

confidence: 98%

“…Three phenotypes were considered for AR: two binary phenotypes based on self-reporting (1) diagnosis (AR bin1 ) and (2) symptoms (AR bin2 ) according to a standardized questionnaire and a categorical ordered trait (AR cat ) based on a score computed from various items related to AR. 17 The asthma phenotype was based on answers to a questionnaire plus the presence of BHR. Linkage analyses were conducted using the maximum likelihood binomial (MLB) method, 18 developed for linkage analysis of binary and ordered categorical traits in sibships.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Genome screen in the French EGEA study: detection of linked regions shared or not shared by allergic rhinitis and asthma

et al. 2005

View full text Add to dashboard Cite

In the sample of 295 French EGEA families with at least one asthmatic subject, a genome screen was conducted to identify potential linkage regions specific either to allergic rhinitis (AR) or to asthma as well as those shared by the two diseases. Two binary rhinitis phenotypes based on (1) diagnosis (AR bin1 ) and (2) symptoms (AR bin2 ) and a categorical ordered trait (AR cat ) were considered. Asthma phenotype was based on answers to a standardized questionnaire plus the presence of bronchial hyper-responsiveness. Linkage analyses were conducted using the maximum likelihood binomial (MLB) method. These analyses provided potential evidence for linkage to three regions in the whole sample: 1p31 for the phenotype defined by AR bin2 plus asthma (P ¼ 0.00016), 2q32 for AR bin2 (P ¼ 0.00016) and 3p24-p14 for AR cat (P ¼ 0.001). Two other regions were detected in the subset of 185 families with at most one asthmatic sib: 9p22 and 9q22-q34 for AR bin1 (P ¼ 0.001 and 0.0007, respectively). No region showed evidence for linkage to asthma without being also linked to AR. While 1p31 may contain a genetic determinant common to asthma and AR, 2q32, 3p24-p14, 9p22 and 9q22-q34 are more likely to harbor genetic factors specific to AR. Genes and Immunity (2005) 6, 95-102.

show abstract

Section: Phenotypes Analyzedmentioning

confidence: 98%

Section: Introductionmentioning

confidence: 99%

Genome screen in the French EGEA study: detection of linked regions shared or not shared by allergic rhinitis and asthma

et al. 2005

View full text Add to dashboard Cite

show abstract

“…or 'Has your child ever had another allergic rhinitis?' with the indication of the type of allergen (question not included in ISAAC) [10]. For the purpose of the analysis, the following four groups of children were defined: controls (C, children without asthma and rhinitis), with asthma (A), with rhinitis (R), and with asthma and rhinitis (AR).…”

Section: Outcomes Of Interestmentioning

confidence: 99%

Interrelationships among asthma, atopy, rhinitis and exhaled nitric oxide in a population‐based sample of children

Jouaville¹,

Annesi‐Maesano

Nguyễn³

et al. 2003

Clin Experimental Allergy

Self Cite

116

View full text Add to dashboard Cite

SummaryBackground Exhaled nitric oxide (eNO) has attracted increasing interest as a non-invasive marker of airway inflammation in asthma. However, little evidence exists on the influences exerted on eNO by the interrelations among atopic status, asthma and rhinitis. Methods Among the 1156 children who participated in a large-scale epidemiological survey on asthma and allergies (ISAAC II: International Study of Asthma and Allergies in Childhood Phase II) in the city of Clermont-Ferrand, 53 asthmatics without corticosteroid treatment and 96 nonasthmatics were invited to perform eNO and skin prick tests (SPTs) to 12 common allergens. Results Atopic asthmatic children had higher eNO than non-atopic asthmatic children (28.979.1 vs. 17.1713.1 p.p.b.; P 5 0.0004) with a significant increase when one SPT or more are positive (26.577.8 vs. 17.1713.1 p.p.b.; P 5 0.03). Similarly, non-asthmatic, atopic subjects had higher eNO than non-atopic subjects with a significant increase when two SPTs or more are positive (19.479.8 vs. 11.7 76.7 p.p.b.; P 5 0.003). In the case of equal levels of positive SPTs (0, 1, X2), asthmatic children always had higher eNO than non-asthmatic ones. Furthermore, among non-asthmatic children, the eNO level increased only in atopics who had rhinitis (20.7713 vs. 12.576.4 p.p.b. in atopic controls (subjects without rhinitis and asthma) and 12.376.6 p.p.b. in non-atopic controls; P 5 0.001), whereas among asthmatic children, eNO level increased in atopics independently of rhinitis (28.279.5 p.p.b. in those with rhinitis and 30.978.1 p.p.b. in those without) as well as in nonatopics with rhinitis (22.5717.2 p.p.b.). Conclusions Our data suggest that besides atopy and asthma, allergic rhinitis should also be taken into account in the assessment of eNO.

show abstract

“…[1,2] The reason for the lower prevalence of AR in our AS series may be attributed to several factors. First, prevalence studies based on questionnaires are more likely to yield an exaggerated rate of disease.…”

Section: Volume 5 | Issue 1 | April 2015mentioning

confidence: 99%

“…Its prevalence is estimated as 5-40% with a tendency to increase. [1,2] Beyond the data collected from studies performed on large populations, an important contribution to …”

mentioning

confidence: 99%

A preliminary report on the prevalence and clinical features of allergic rhinitis in ankylosing spondylitis patients

Turgan¹,

Ural²,

Işik³

et al. 2015

ENT Updates

View full text Add to dashboard Cite

Allergic rhinitis (AR) is a common disorder that constitutes a considerable burden both for the individual patient and the society. It is important due to its high prevalence, adverse effects on the quality of life and sleep, impairment of work/school performance and the links with other comorbidities. Its prevalence is estimated as 5-40% with a tendency to increase. [1,2] Beyond the data collected from studies performed on large populations, an important contribution to Conclusion:Our results demonstrate that prevalence of allergic rhinitis is lower in ankylosing spondylitis patients. However, clinical and pathophysiological features of allergic rhinitis accompanying autoimmune diseases must be investigated in further trials.

show abstract

The score for allergic rhinitis (SFAR): a simple and valid assessment method in population studies

Abstract: The newly a priori proposed Score For Allergic Rhinitis (SFAR) is easy to use and can be useful to estimate prevalence and to study causation of AR in population settings.

Cited by 156 publications

References 14 publications

Genome screen in the French EGEA study: detection of linked regions shared or not shared by allergic rhinitis and asthma

Genome screen in the French EGEA study: detection of linked regions shared or not shared by allergic rhinitis and asthma

Interrelationships among asthma, atopy, rhinitis and exhaled nitric oxide in a population‐based sample of children

A preliminary report on the prevalence and clinical features of allergic rhinitis in ankylosing spondylitis patients

Contact Info

Product

Resources

About